Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Century acquires Empirica: treating GBM with off-the-shelf cell therapies

By acquiring Empirica and its work on glioblastoma (GBM), Century Therapeutics has taken its first step towards developing off-the-shelf cell therapies for solid tumours. How could this deal improve the GBM treatment paradigm?

Close
Close
Close

Go Top